Lawrence Bloch

Lawrence Bloch

Company: Infinity Pharmaceuticals

Job title: President


Panel Discussion: Evaluating the Synergistic Potential of Combination with Other Frontline Treatments to Distinguish the Best Combination Approach 4:30 pm

Combining macrophage therapy with Radiotherapy Utilizing other small molecules (e.g. PARP inhibitors, STING agonists) with first-in-class antibody targeting the myeloid-specific ILT4 receptor Developing clinical trial strategy to determine which combinations have the most synergistic/additive potentialRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.